News | February 09, 2012

Boston Scientific WallFlex Enteral Stents Safe, Effective in Three Clinical Registries

February 9, 2012 — Boston Scientific announced positive results from three studies of the WallFlex enteral stent systems, a family of self-expanding metal stents (SEMS) used to alleviate obstructive symptoms caused by cancers of the gastrointestinal tract.  The studies, published in peer-reviewed medical journals, determined the WallFlex stents to be safe and effective for the treatment of malignant colorectal and gastroduodenal obstruction.  

The first publication appeared in the October 2011 issue of Gastrointestinal Endoscopy, and reported the short-term safety and effectiveness of the Boston Scientific WallFlex enteral colonic stent for relieving malignant colorectal obstruction.  This 447-patient study represents the largest prospective, multi-center series to date of colonic SEMS placement in both palliative and bridge-to-surgery settings. The WallFlex Enteral colonic stent was determined to be safe and effective for treatment of malignant colorectal obstruction with a clinical success rate of 90.5 percent.  The authors determined that SEMS allowed most bridge-to-surgery patients to have an elective surgical procedure without a colostomy and most incurable patients to receive minimally invasive palliation instead of surgery.

"Based on results from this study, physicians should consider SEMS as a first-line treatment option for patients with malignant colorectal obstruction," said Soren Meisner, M.D., of Bispebjerg Hospital in Copenhagen, Denmark and principal author of the study.  "SEMS provide patients with a less-invasive alternative to surgery and may also improve quality of life."

The second publication, appearing in the December 2011 issue of The American Journal of Gastroenterology, reports on 182 patients from the WallFlex colonic stent registries that received a WallFlex colonic stent as a bridge to surgery.  Findings show rates of 97.8 percent procedural success and 94 percent clinical success, prompting the authors to conclude that the stent is both safe and effective as a bridge-to-surgery treatment in patients with acute malignant obstruction.

The third publication were the results from the international, multi-center WallFlex duodenal stent registry and were published in the January 2012 issue of Digestive and Liver Disease.  The largest prospective study of its kind assessed the treatment of malignant gastroduodenal obstruction in 202 patients.  Results confirmed the safety and effectiveness of the WallFlex enteral duodenal stent, which demonstrated procedural and clinical success rates of 98 and 91 percent, respectively.  The authors concluded that adoption of duodenal stenting could result in this minimally invasive procedure becoming standard of care when managing inoperable patients with advanced cancer experiencing gastric outlet obstruction.

For more information: www.bostonscientific.com

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
Reduced hippocampal volume on MRI

This figure shows reduced hippocampal volume over the course of 6 years as seen on progressive volumetric analysis and also coronal MRI evaluations (arrows).Progressive volume loss in the mesial temporal lobe on MRI is a characteristic imaging feature of AD. This patient was a case of Alzheimer’s Dementia.

 

News | Neuro Imaging | June 12, 2018
According to a UCLA Medical Center study, a new technology shows the potential to help doctors better determine when...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
Lung Decision Precision
News | Lung Cancer | June 04, 2018
For smokers and former smokers, the threat of lung cancer always lurks in the shadows.
New Ultrasound Guidelines Reliably Identify Children Who Should be Biopsied for Thyroid Cancer

Image courtesy of Loyola Medicine

News | Pediatric Imaging | May 29, 2018
A Loyola Medicine study has found that new ultrasound guidelines can reliably identify pediatric patients who should be...
Overlay Init